In vivo experiments showed that treatment with Metformin of mice carrying PDAC xenograft derived from HNF4G-overexpressing T3M4 cells in the pancreas significantly reduced the tumor burden and prolonged survival time compared with treatment with vehicle (Fig. 5C and 5D). Here, HNF4G is linked to neoplasm.